🌿Groff Health Inc's Application to Manufacture Controlled Substances
Groff Health Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊DEA Adjusts Production Quota for Lisdexamfetamine and d-Amphetamine
The Drug Enforcement Administration (DEA) is adjusting the 2025 aggregate production quota for the schedule II controlled substances lisdexamfetamine and d-amphetamine (for conversion). In making this determination, DEA has considered the factors set forth in 21 CFR 1303.13(b) in accordance with 21 U.S.C. 826(a) and is expediting publication of this determination to comply with the timeframes specified in 21 U.S.C. 826(h)(1).
Learn More🏥DEA Revokes Dentist Registration for Lack of State License
The Drug Enforcement Administration issued an Order to Show Cause, proposing the revocation of Eric Andersen, D.D.S.'s DEA registration based on his lack of authority to practice dentistry in Illinois. The order emphasizes compliance with state licensing laws, and failure to contest leads to assumed admission of allegations.
Learn More🚑Summary of DEA Registration Revocation Impact on Healthcare Practices
The DEA has revoked the registration of Dr. Haroon Hameed due to serious violations of the Controlled Substances Act, including habitual substance abuse while treating patients. This decision underscores the regulatory framework governing medical practitioners and aims to protect public health by enforcing compliance with controlled substances laws.
Learn More💼New Regulations on Fentanyl-Related Substances and Business Impact
The Drug Enforcement Administration places seven fentanyl- related substances, as identified in this final rule, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers in schedule I of the Controlled Substances Act. The regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle these seven specific controlled substances will continue to apply as a result of this action.
Learn More💊Catalent Greenville Inc. Applies for Controlled Substances Import License
Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Learn More💊DEA Notice on Fisher Clinical Services' Importer Application
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More🚫DEA Denies Registration For Vet Due to License Suspension
The DEA issued a decision denying Chanelle D. Remien's application for a Certificate of Registration, citing her suspended veterinary license in Washington as the reason. The agency emphasized the necessity of state authorization for the handling of controlled substances, highlighting the consequences of failing to maintain proper licensing in regulated professions.
Learn More💊DEA Notice on Controlled Substance Import Application by Biopharmaceutical Research Company
Biopharmaceutical Research Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Learn More🧪DOJ Proposes Annual Reporting Requirements for Chemical Manufacturers
The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Learn More